Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

86
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
86
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

101
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
101
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

224
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
224
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

149
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
149
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

161
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
161
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visualizing stigma and HIV service engagement: a participatory approach using causal loop diagrams.

BMC public health·2026
Same author

Temporal Connectivity of Social Contact Networks in Urban and Rural India.

Epidemiology (Cambridge, Mass.)·2026
Same author

Cost-effectiveness of Commercial or Traditional Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Long-Acting Injectable Cabotegravir HIV PrEP Uptake, Adherence, and Persistence in Two Large US Integrated Healthcare Systems.

Journal of acquired immune deficiency syndromes (1999)·2026
Same author

Role of casual contact in drug-resistant tuberculosis transmission: a molecular epidemiology study.

American journal of respiratory and critical care medicine·2026
Same author

Modeling the impact of adherence to U.S. isolation and masking guidance on SARS-CoV-2 transmission in office workplaces in 2021-2022.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Sep 11, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Meta-Modeling as a Variance-Reduction Technique for Stochastic Model-Based Cost-Effectiveness Analyses.

Zongbo Li1, Gregory S Knowlton1, Margo M Wheatley1

  • 1Division of Health Policy and Management, University of Minnesota, School of Public Health, Minneapolis, MN, USA.

Medical Decision Making : an International Journal of the Society for Medical Decision Making
|August 15, 2025
PubMed
Summary

Stochastic noise in cost-effectiveness analysis (CEA) can obscure results. Meta-modeling reduces this noise in simulations, improving the reliability of probabilistic sensitivity analyses (PSA) without increasing computational burden.

Keywords:
Monte Carlocost-effectiveness analysisprobabilistic sensitivity analysisstochastic uncertaintyvariance reduction

More Related Videos

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.4K
Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm
11:53

Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm

Published on: December 9, 2012

13.0K

Related Experiment Videos

Last Updated: Sep 11, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.4K
Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm
11:53

Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm

Published on: December 9, 2012

13.0K

Area of Science:

  • Health Economics
  • Computational Modeling
  • Biostatistics

Background:

  • Stochastic models in cost-effectiveness analysis (CEA) can exhibit run-to-run variability, where noise exceeds intervention effects, especially with small individual-level efficacy.
  • This stochastic noise complicates probabilistic sensitivity analyses (PSA), obscuring the impact of parameter uncertainty on CEA outcomes.
  • Unintuitive results, such as interventions appearing to reduce quality-adjusted life-years (QALYs), can arise from excessive stochastic noise.

Purpose of the Study:

  • To evaluate meta-modeling as a variance-reduction technique for mitigating stochastic noise in PSA.
  • To assess if meta-modeling can preserve parameter uncertainty while reducing noise in complex simulation models.
  • To improve the reliability and interpretability of CEA results derived from stochastic models.

Main Methods:

  • Applied three meta-modeling techniques (linear regression, generalized additive models, artificial neural networks) to two simulation models: a Sick-Sicker model and an agent-based HIV transmission model.
  • Conducted PSA on both models and assessed meta-model performance using R-squared and root mean squared error (RMSE) on a validation dataset.
  • Compared PSA results by analyzing scatter plots of incremental costs and QALYs, cost-effectiveness acceptability curves (CEACs), and the frequency of unintuitive outcomes.

Main Results:

  • Meta-modeling substantially reduced variance in incremental costs and QALYs in the Sick-Sicker model, nearly eliminating unintuitive results with good model fit (high R-squared, low RMSE).
  • In the HIV agent-based model, all three meta-models effectively reduced outcome variability while preserving parameter uncertainty.
  • Meta-modeling yielded more informative CEACs, increasing the probability of identifying cost-effective strategies in the HIV model.

Conclusions:

  • Meta-modeling is an effective technique for reducing stochastic noise in simulation models used for CEA.
  • This approach enhances the reliability of PSA results by preserving parameter uncertainty without requiring an impractical number of simulations.
  • Meta-modeling improves the interpretability of CEA outcomes from complex stochastic models, offering a valuable tool for health economic evaluations.